Anti-MOZ [127A]

MOZ fusion proteins block normal differentiation of myeloid progenitors resulting in AML (acute Myloid Leukaemia).Recombinant fragment of human MOZ (172-321aa) produced as a fusion protein in E. coli.

Contributors

Inventor Institute
David Heery ; Tasneem Ritchie University of Oxford
Cat. #: 151838
Tool sub type: Primary antibody
Unit size: 100 ug
Research Fields: Genetics
Application: IP ; WB ; IP ; WB
Target: Monocytic Leukaemia Zinc Finger Protein, MOZ, MYST3
Reactivity: Human
Clone: 127A
Host: Mouse
Class: Monoclonal
Product description: MOZ fusion proteins block normal differentiation of myeloid progenitors resulting in AML (acute Myloid Leukaemia).Recombinant fragment of human MOZ (172-321aa) produced as a fusion protein in E. coli.
Conjugation: Unconjugated
Isotype: IgG3 kappa
Molecular weight: 225 kDa
Immunogen: GST-MOZ (172-321aa) recombinant protein human MOZ
Target background: MOZ fusion proteins block normal differentiation of myeloid progenitors resulting in AML (acute Myloid Leukaemia).Recombinant fragment of human MOZ (172-321aa) produced as a fusion protein in E. coli.
Format: Liquid
Concentration: 1 mg/ml
Storage buffer: PBS with 0.02% azide
Storage conditions: -80° C
Shipping conditions: Dry ice
References:

Elizabeth Deeves. 2012. PhD thesis. Novel functions of the MOZ double PHD finder domain.

Related Tools for Antibodies

Cat. # Tool Name
151030 Anti-Progesterone [11P14] Key Info View Tool
151016 Anti-CyclinA [E72.1] Key Info View Tool
151021 Anti-CyclinB1 [V152] Key Info View Tool
151022 Anti-IL12 [1-1A4] Key Info View Tool
151027 Anti-HSVICP8 [10A3] Key Info View Tool

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.